APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs For Travelers' Diarrhea (TD)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drugs For Travelers' Diarrhea (TD) Market Outlook and Growth Opportunities 2026

30 December 2025196 pages

Choose your research edition.

Industry ResearchDrugs For Travelers' Diarrhea (TD) Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs For Travelers' Diarrhea (TD) Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Drugs For Travelers' Diarrhea (TD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs For Travelers' Diarrhea (TD) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs For Travelers' Diarrhea (TD) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Drugs For Travelers' Diarrhea (TD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drugs For Travelers' Diarrhea (TD) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drugs For Travelers' Diarrhea (TD) market include Sun Pharmaceutical Industries Ltd., Johnson & Johnson, Bayer AG, Valneva SE, Perrigo Company Plc, Norgine, Immuron, COSMO PHARMACEUTICALS and Bausch Health Companies Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drugs For Travelers' Diarrhea (TD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs For Travelers' Diarrhea (TD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs For Travelers' Diarrhea (TD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drugs For Travelers' Diarrhea (TD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs For Travelers' Diarrhea (TD) Segment by Company

Sun Pharmaceutical Industries Ltd.

Johnson & Johnson

Bayer AG

Valneva SE

Perrigo Company Plc

Norgine

Immuron

COSMO PHARMACEUTICALS

Bausch Health Companies Inc.

Drugs For Travelers' Diarrhea (TD) Segment by Type

Antidiarrheal Agents

Oral Rehydration Therapy (ORS)

Antibiotics

Others

Drugs For Travelers' Diarrhea (TD) Segment by Application

Adults

Children

Drugs For Travelers' Diarrhea (TD) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Drugs For Travelers' Diarrhea (TD) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Drugs For Travelers' Diarrhea (TD) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drugs For Travelers' Diarrhea (TD) significant trends, drivers, influence factors in global and regions.

6. To analyze Drugs For Travelers' Diarrhea (TD) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs For Travelers' Diarrhea (TD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs For Travelers' Diarrhea (TD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs For Travelers' Diarrhea (TD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drugs For Travelers' Diarrhea (TD) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs For Travelers' Diarrhea (TD) industry.

Chapter 3: Detailed analysis of Drugs For Travelers' Diarrhea (TD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Drugs For Travelers' Diarrhea (TD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Drugs For Travelers' Diarrhea (TD) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drugs For Travelers' Diarrhea (TD) Industry Trends Table 2. Drugs For Travelers' Diarrhea (TD) Industry Drivers Table 3. Drugs For Travelers' Diarrhea (TD) Industry Opportunities and Challenges Table 4. Drugs For Travelers' Diarrhea (TD) Industry Restraints Table 5. Global Drugs For Travelers' Diarrhea (TD) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drugs For Travelers' Diarrhea (TD) Revenue Share by Company (2021-2026) Table 7. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share by Company (2021-2026) Table 9. Global Drugs For Travelers' Diarrhea (TD) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Drugs For Travelers' Diarrhea (TD) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Drugs For Travelers' Diarrhea (TD) Key Company Manufacturing Base & Headquarters Table 12. Global Drugs For Travelers' Diarrhea (TD) Company, Product Type & Application Table 13. Global Drugs For Travelers' Diarrhea (TD) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Drugs For Travelers' Diarrhea (TD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antidiarrheal Agents Table 18. Significant Companies of Oral Rehydration Therapy (ORS) Table 19. Significant Companies of Antibiotics Table 20. Significant Companies of Others Table 21. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share by Type (2021-2026) Table 25. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share by Type (2027-2032) Table 26. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type (2021-2026) Table 30. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Adults Table 32. Significant Companies of Children Table 33. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share by Application (2021-2026) Table 37. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share by Application (2027-2032) Table 38. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application (2021-2026) Table 42. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application (2027-2032) Table 43. Global Drugs For Travelers' Diarrhea (TD) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Drugs For Travelers' Diarrhea (TD) Sales by Region (2021-2026) & (K Units) Table 45. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Region (2021-2026) Table 46. Global Drugs For Travelers' Diarrhea (TD) Sales by Region (2027-2032) & (K Units) Table 47. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Region (2027-2032) Table 48. Global Drugs For Travelers' Diarrhea (TD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Region (2021-2026) Table 51. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Region (2027-2032) Table 53. Global Drugs For Travelers' Diarrhea (TD) Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Drugs For Travelers' Diarrhea (TD) Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Drugs For Travelers' Diarrhea (TD) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026) & (K Units) Table 58. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Country (2021-2026) Table 59. Global Drugs For Travelers' Diarrhea (TD) Sales by Country (2027-2032) & (K Units) Table 60. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Country (2027-2032) Table 61. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Drugs For Travelers' Diarrhea (TD) Sales Value Market Share by Country (2021-2026) Table 63. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Drugs For Travelers' Diarrhea (TD) Sales Value Market Share by Country (2027-2032) Table 65. Sun Pharmaceutical Industries Ltd. Company Information Table 66. Sun Pharmaceutical Industries Ltd. Business Overview Table 67. Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 69. Sun Pharmaceutical Industries Ltd. Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Bayer AG Company Information Table 76. Bayer AG Business Overview Table 77. Bayer AG Drugs For Travelers' Diarrhea (TD) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Bayer AG Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 79. Bayer AG Recent Development Table 80. Valneva SE Company Information Table 81. Valneva SE Business Overview Table 82. Valneva SE Drugs For Travelers' Diarrhea (TD) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Valneva SE Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 84. Valneva SE Recent Development Table 85. Perrigo Company Plc Company Information Table 86. Perrigo Company Plc Business Overview Table 87. Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 89. Perrigo Company Plc Recent Development Table 90. Norgine Company Information Table 91. Norgine Business Overview Table 92. Norgine Drugs For Travelers' Diarrhea (TD) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Norgine Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 94. Norgine Recent Development Table 95. Immuron Company Information Table 96. Immuron Business Overview Table 97. Immuron Drugs For Travelers' Diarrhea (TD) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Immuron Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 99. Immuron Recent Development Table 100. COSMO PHARMACEUTICALS Company Information Table 101. COSMO PHARMACEUTICALS Business Overview Table 102. COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 104. COSMO PHARMACEUTICALS Recent Development Table 105. Bausch Health Companies Inc. Company Information Table 106. Bausch Health Companies Inc. Business Overview Table 107. Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Portfolio Table 109. Bausch Health Companies Inc. Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Drugs For Travelers' Diarrhea (TD) Distributors List Table 113. Drugs For Travelers' Diarrhea (TD) Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Drugs For Travelers' Diarrhea (TD) Product Image Figure 2. Global Drugs For Travelers' Diarrhea (TD) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Drugs For Travelers' Diarrhea (TD) Sales (2021-2032) & (K Units) Figure 5. Global Drugs For Travelers' Diarrhea (TD) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Drugs For Travelers' Diarrhea (TD) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antidiarrheal Agents Image Figure 10. Oral Rehydration Therapy (ORS) Image Figure 11. Antibiotics Image Figure 12. Others Image Figure 13. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share by Type (2021-2032) Figure 16. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type (2021-2032) Figure 19. Adults Image Figure 20. Children Image Figure 21. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share by Application (2021-2032) Figure 24. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application (2021-2032) Figure 27. Global Drugs For Travelers' Diarrhea (TD) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Drugs For Travelers' Diarrhea (TD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Drugs For Travelers' Diarrhea (TD) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Drugs For Travelers' Diarrhea (TD) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Antidiarrheal Agents
  • Oral Rehydration Therapy (ORS)
  • Antibiotics
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Sun Pharmaceutical Industries Ltd.
  • Johnson & Johnson
  • Bayer AG
  • Valneva SE
  • Perrigo Company Plc
  • Norgine
  • Immuron
  • COSMO PHARMACEUTICALS
  • Bausch Health Companies Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032)
  4. 1.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume (2021-2032)
  5. 1.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Drugs For Travelers' Diarrhea (TD) Market Dynamics
  1. 2.1 Drugs For Travelers' Diarrhea (TD) Industry Trends
  2. 2.2 Drugs For Travelers' Diarrhea (TD) Industry Drivers
  3. 2.3 Drugs For Travelers' Diarrhea (TD) Industry Opportunities and Challenges
  4. 2.4 Drugs For Travelers' Diarrhea (TD) Industry Restraints
3 Drugs For Travelers' Diarrhea (TD) Market by Company
  1. 3.1 Global Drugs For Travelers' Diarrhea (TD) Company Revenue Ranking in 2025
  2. 3.2 Global Drugs For Travelers' Diarrhea (TD) Revenue by Company (2021-2026)
  3. 3.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Company (2021-2026)
  4. 3.4 Global Drugs For Travelers' Diarrhea (TD) Average Price by Company (2021-2026)
  5. 3.5 Global Drugs For Travelers' Diarrhea (TD) Company Ranking (2024-2026)
  6. 3.6 Global Drugs For Travelers' Diarrhea (TD) Company Manufacturing Base and Headquarters
  7. 3.7 Global Drugs For Travelers' Diarrhea (TD) Company Product Type and Application
  8. 3.8 Global Drugs For Travelers' Diarrhea (TD) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Drugs For Travelers' Diarrhea (TD) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Drugs For Travelers' Diarrhea (TD) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Drugs For Travelers' Diarrhea (TD) Market by Type
  1. 4.1 Drugs For Travelers' Diarrhea (TD) Type Introduction
  2. 4.1.1 Antidiarrheal Agents
  3. 4.1.2 Oral Rehydration Therapy (ORS)
  4. 4.1.3 Antibiotics
  5. 4.1.4 Others
  6. 4.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type
  7. 4.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type
  11. 4.3.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2021-2032)
  13. 4.3.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type (2021-2032)
5 Drugs For Travelers' Diarrhea (TD) Market by Application
  1. 5.1 Drugs For Travelers' Diarrhea (TD) Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application
  5. 5.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application
  9. 5.3.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application (2021-2032)
6 Drugs For Travelers' Diarrhea (TD) Regional Sales and Value Analysis
  1. 6.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Region (2021-2032)
  3. 6.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Region: 2021-2026
  4. 6.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Region (2027-2032)
  5. 6.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2027-2032)
  9. 6.5 Global Drugs For Travelers' Diarrhea (TD) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032)
  12. 6.6.2 North America Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032)
  15. 6.7.2 Europe Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032)
  21. 6.9.2 South America Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value Share by Country, 2025 VS 2032
7 Drugs For Travelers' Diarrhea (TD) Country-level Sales and Value Analysis
  1. 7.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
  4. 7.3.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2026)
  5. 7.3.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Country (2027-2032)
  6. 7.4 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Drugs For Travelers' Diarrhea (TD) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Drugs For Travelers' Diarrhea (TD) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Drugs For Travelers' Diarrhea (TD) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical Industries Ltd.
  2. 8.1.1 Sun Pharmaceutical Industries Ltd. Company Information
  3. 8.1.2 Sun Pharmaceutical Industries Ltd. Business Overview
  4. 8.1.3 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Bayer AG
  14. 8.3.1 Bayer AG Company Information
  15. 8.3.2 Bayer AG Business Overview
  16. 8.3.3 Bayer AG Drugs For Travelers' Diarrhea (TD) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer AG Drugs For Travelers' Diarrhea (TD) Product Portfolio
  18. 8.3.5 Bayer AG Recent Developments
  19. 8.4 Valneva SE
  20. 8.4.1 Valneva SE Company Information
  21. 8.4.2 Valneva SE Business Overview
  22. 8.4.3 Valneva SE Drugs For Travelers' Diarrhea (TD) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Valneva SE Drugs For Travelers' Diarrhea (TD) Product Portfolio
  24. 8.4.5 Valneva SE Recent Developments
  25. 8.5 Perrigo Company Plc
  26. 8.5.1 Perrigo Company Plc Company Information
  27. 8.5.2 Perrigo Company Plc Business Overview
  28. 8.5.3 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Portfolio
  30. 8.5.5 Perrigo Company Plc Recent Developments
  31. 8.6 Norgine
  32. 8.6.1 Norgine Company Information
  33. 8.6.2 Norgine Business Overview
  34. 8.6.3 Norgine Drugs For Travelers' Diarrhea (TD) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Norgine Drugs For Travelers' Diarrhea (TD) Product Portfolio
  36. 8.6.5 Norgine Recent Developments
  37. 8.7 Immuron
  38. 8.7.1 Immuron Company Information
  39. 8.7.2 Immuron Business Overview
  40. 8.7.3 Immuron Drugs For Travelers' Diarrhea (TD) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Immuron Drugs For Travelers' Diarrhea (TD) Product Portfolio
  42. 8.7.5 Immuron Recent Developments
  43. 8.8 COSMO PHARMACEUTICALS
  44. 8.8.1 COSMO PHARMACEUTICALS Company Information
  45. 8.8.2 COSMO PHARMACEUTICALS Business Overview
  46. 8.8.3 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Portfolio
  48. 8.8.5 COSMO PHARMACEUTICALS Recent Developments
  49. 8.9 Bausch Health Companies Inc.
  50. 8.9.1 Bausch Health Companies Inc. Company Information
  51. 8.9.2 Bausch Health Companies Inc. Business Overview
  52. 8.9.3 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Portfolio
  54. 8.9.5 Bausch Health Companies Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drugs For Travelers' Diarrhea (TD) Value Chain Analysis
  2. 9.1.1 Drugs For Travelers' Diarrhea (TD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drugs For Travelers' Diarrhea (TD) Sales Mode & Process
  6. 9.2 Drugs For Travelers' Diarrhea (TD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drugs For Travelers' Diarrhea (TD) Distributors
  9. 9.2.3 Drugs For Travelers' Diarrhea (TD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst